Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas M Strømme

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Cancer|August 20, 2018
Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancerIna A Eilertsen, Anita Sveen, Jonas M Strømme, et al.
Cancer Letters|November 4, 2019
Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancerIna A Eilertsen, Seyed H Moosavi, Jonas M Strømme, et al.
Neoplasia (New York, N.Y.)|June 30, 2024
GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancerMari Bogaard, Jonas M Strømme, Susanne G Kidd, et al.
Cancer Gene Therapy|February 23, 2022
Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneityJonas M Strømme, Bjarne Johannessen, Susanne G Kidd, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Cancer|August 20, 2018
Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancerIna A Eilertsen, Anita Sveen, Jonas M Strømme, et al.
Cancer Letters|November 4, 2019
Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancerIna A Eilertsen, Seyed H Moosavi, Jonas M Strømme, et al.
Neoplasia (New York, N.Y.)|June 30, 2024
GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancerMari Bogaard, Jonas M Strømme, Susanne G Kidd, et al.
Cancer Gene Therapy|February 23, 2022
Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneityJonas M Strømme, Bjarne Johannessen, Susanne G Kidd, et al.
Pageof 1